KRAS and colorectal carcinoma: To determine whether the same dependency is evident in human KRAS-mutant CRC cell lines, we evaluated this therapeutic approach in two isogenic human cell line systems (LIM1215 and SW48) that comprise a series of KRAS-mutant alleles.